Meet our team
Diagnostic Ventures
Co-Founder & CEO
Brian brings over 30 years of leadership and innovation to modern healthcare. His experience spans senior sales and business development roles, founding and chairing a healthcare SaaS company, active angel investing, and co-inventing diagnostic patent applications.
Co-Founder & COO
Devin brings over 18 years of commercial and operational leadership. He served as VP of Sales for a nationwide infrastructure firm valued at $250M and brings go-to-market, healthcare SaaS, and senior advisory experience.
President
Anthony is a MedTech executive and global market strategist whose career includes more than $500M in revenue expansion, two IPOs, and eight acquisitions totaling $3.75B, with leadership roles at Qualcomm, Quidel, and Cardinal Health.
Advisor — Commercialization
Christina is CEO of Rapid Commercialization Partners and a biotechnology executive with over 25 years of experience advancing commercialization, launch readiness, and market access, including roles with Alexion, Agile, and PTC.
Advisor — Clinical Strategy
Leesa brings decades of clinical leadership across global trials and business strategy, with experience at RenovoRx, Evotec, Otsuka, IQVIA, PPD, and Omnicare.
Advisors — Investors & Capital
After each losing a parent to sepsis, Mark and Norma became deeply committed to the mission. As founders of Venture Starters, they have mentored entrepreneurs and hosted more than 4,500 founder pitches focused on global challenges.
Advisor — Clinical
Dr. Kerbel brings deep experience in hospital medicine, sepsis care, and clinical informatics as a UCLA Health medical director, physician informaticist, hospitalist, and clinical professor.
Advisor — Chemical Engineering
Dr. Pitt is a BYU Professor of Chemical Engineering and microfluidics expert with more than 235 publications and eight patents. His NIH-funded work underpins the company’s centrifugal micro-disc technology.
Advisor — Genetics
Dr. Hill is a BYU Associate Professor specializing in molecular genetics, high-throughput sequencing, bioinformatics, liquid biopsy, and cell-free DNA analysis.
Move faster with us
Every minute counts when diagnosing sepsis. We are pioneering the world’s fastest comprehensive pathogen identification system to eliminate the wait for blood cultures and save lives. Reach out to learn more about our technology, clinical timeline, or partnership opportunities.
Contact us